LENZ
NASDAQ · Pharmaceuticals
Lenz Therapeutics Inc
$3.01
-0.45 (-13.01%)
Open$3.44
Previous Close$3.46
Day High$3.44
Day Low$3.00
52W High$32.13
52W Low$2.80
Volume—
Avg Volume1.61M
Market Cap109.97M
P/E Ratio—
EPS$-4.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+364.5% upside
Current
$3.01
$3.01
Target
$13.98
$13.98
$9.74
$13.98 avg
$16.17
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 24.20M | 61.59M | 55.54M |
| Net Income | -104,137,310 | 19.38M | 14.59M |
| Profit Margin | -430.3% | 31.5% | 26.3% |
| EBITDA | -115,200,278 | 32.48M | 26.94M |
| Free Cash Flow | — | 24.80M | 19.95M |
| Rev Growth | — | +17.7% | +18.8% |
| Debt/Equity | — | 0.99 | 1.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |